Company / R&D per Share
Day One Biopharmaceuticals, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.46
FY2025
5-year range
$1.18 / $2.61
FY2021-FY2025
Trend
-43.9%
vs FY2024
Sector context
#128 of 207
Health Care
What the data says
At $1.46, Day One Biopharmaceuticals, Inc.'s r&d per share ranks #128 of 207 in the Health Care sector. Declined from $1.64 to $1.46 over the past 2 years.
Based on SEC 10-K filings.
1.46 in FY2025 with a 5-year CAGR of -2.3%.
Declined from $1.64 to $1.46 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Sector benchmark
#128 of 207 in Health CareTop 62% of 207This company $1.46 Sector average $12.26
▼
-88.0% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 43.9% year-over-year.
- Ranks #128 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2021.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.46 | -43.9% |
| FY2024 | $2.61 | +59.5% |
| FY2023 | $1.64 | +25.1% |
| FY2022 | $1.31 | +10.9% |
| FY2021 | $1.18 | -28.3% |
| FY2020 | $1.65 | -29.8% |
| FY2019 | $2.35 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026